Malignant tumor is one of the difficult problems in the world medical field, and the treatment of malignant tumor is difficult to determine because of the high recurrence and metastasis. In recent years, the method of treating malignant tumor by immune cells, tumor biological immune therapy, has its unique anti-tumor effect by enhancing immune function of patients, which is known as the fourth major cancer treatment model following surgery, radiotherapy and chemotherapy.
CIK biological immune therapy to open up a new situation of tumor treatment
At present, many cancer patients still think the most common tumor treatment, radiotherapy, chemotherapy and operation only. Along with the development of the mechanism of tumor development, tumor immunology, molecular biology, biotechnology, the development of tumor biological treatment has become the fourth major models of cancer treatment. And biological immune cell therapy for its safety, toxicity and clinical benefit rate is high, and can with current clinical the routine treatment with the flexibility to use and has attracted much attention. The use of anti tumor immune cells can significantly reduce the recurrence and metastasis, improve the cure rate, immune cells and radiotherapy combined with chemotherapy can significantly reduce the toxic side effects, and can improve the efficiency of the treatment; the treatment of immune cell therapy can be the first choice for patients who are not suitable for radiotherapy.
CIK biological immune therapy can make life rate doubled